Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab-Reference-Cited by-同舟云学术

Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab

Published:2020-02-03 Issue:2 Volume:38 Page:146-152
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Fujimoto Ayumi¹²^ORCID,Hiramoto Nobuhiro²,Yamasaki Satoshi³,Inamoto Yoshihiro⁴,Ogata Masao⁵,Sugio Yasuhiro⁶,Fukuda Takahiro⁴,Uchida Naoyuki⁷,Ikegame Kazuhiro⁸,Matsuoka Ken‐ichi⁹,Shiratori Souichi¹⁰^ORCID,Kondo Tadakazu¹¹^ORCID,Miyamoto Toshihiro¹²,Eto Tetsuya¹³,Ichinohe Tatsuo¹⁴,Kanda Yoshinobu¹⁵^ORCID,Atsuta Yoshiko¹⁶¹⁷,Suzuki Ritsuro¹^ORCID,

Affiliation:

1. Department of Oncology and Hematology Shimane University Hospital Izumo Japan

2. Department of Hematology Kobe City Medical Center General Hospital Kobe Japan

3. Department of Hematology and Clinical Research Institute National Hospital Organization Kyushu Medical Center Fukuoka Japan

4. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

5. Department of Hematology Oita University Faculty of Medicine Oita Japan

6. Department of Internal Medicine, Kitakyushu City Hospital Organization Kitakyushu Municipal Medical Center Kitakyushu Japan

7. Department of Hematology Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital Tokyo Japan

8. Division of Hematology, Department of Internal Medicine Hyogo College of Medicine Nishinomiya Japan

9. Department of Hematology and Oncology Okayama University Hospital Okayama Japan

10. Department of Hematology Hokkaido University Hospital Sapporo Japan

11. Department of Hematology/Oncology, Graduate School of Medicine Kyoto University Kyoto Japan

12. Hematology, Oncology and Cardiovascular Medicine Kyushu University Hospital Fukuoka Japan

13. Department of Hematology Hamanomachi Hospital Fukuoka Japan

14. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan

15. Division of Hematology Jichi Medical University Saitama Medical Center Saitama Japan

16. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

17. Department of Healthcare Administration Nagoya University Graduate School of Medicine Nagoya Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2714

Reference18 articles.

1. Post-Transplantation Lymphoproliferative Disorders in Adults

2. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

3. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

4. Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

5. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients;Transplant International;2023-11-17

2. Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder;Current Oncology Reports;2023-05-10

3. Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy;Viruses;2020-04-08